Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study.

Journal of the American Heart Association·2024

Same author

Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity.

Harvard data science review·2023

Same author

The effect of a multi-component behavior change technique intervention on medication adherence among individuals on primary prevention statin therapy: a dose-finding protocol.

Trials·2023

Same author

Barn-Raising on the Digital Frontier: The L.A.U.N.C.H. Collaborative.

Journal of Appalachian health·2022

Same author

The Landscape of Connected Cancer Symptom Management in Rural America: A Narrative Review of Opportunities for Launching Connected Health Interventions.

Journal of Appalachian health·2022

Same author

Experiencing Cancer in Appalachian Kentucky.

Journal of Appalachian health·2022

Search research articles

Related Experiment Video

Updated: May 30, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Informatics-enabled behavioral medicine in oncology.

Bradford W Hesse¹, Jerry M Suls

¹National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-7365, USA. hesseb@mail.nih.gov

Cancer Journal (Sudbury, Mass.)

|July 30, 2011

Summary

Enhanced informatics and health information technology can integrate behavioral medicine principles into routine cancer care. This approach aims to improve cancer prevention, diagnosis, and treatment by altering patient behavior.

Related Experiment Videos

Last Updated: May 30, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Area of Science:

Health Informatics
Behavioral Medicine
Psycho-oncology

Background:

Physicians face numerous behavioral challenges in cancer prevention, diagnosis, and treatment.
Integrating evidence-based behavioral medicine into oncology care is crucial but often challenging.
The Health Information Technology for Economic and Clinical Health Act of 2009 has spurred innovation in health IT.

Purpose of the Study:

To explore how enhanced informatics can redesign healthcare ecosystems for routine behavioral medicine integration in oncology.
To discuss the role of 'meaningful use' criteria and R&D in advancing behavioral oncology.
To examine the potential of health data for accelerating psycho-oncology discoveries.

Main Methods:

Discussion of the integration of behavioral medicine principles within the cancer control continuum.
Analysis of the impact of health information technology (HIT) and 'meaningful use' criteria.
Exploration of research and development efforts in the health information ecosystem.

Main Results:

Enhanced informatics capacity can facilitate the routine application of behavioral medicine principles in cancer care.
Innovation in health IT, driven by policy and R&D, supports the integration of behavioral science.
Data collected through these systems holds promise for advancing psycho-oncology research.

Conclusions:

Nurturing developments in health informatics and behavioral medicine integration can accelerate progress against cancer.
Altering the behavioral milieu through evidence-based practices is key to improving cancer outcomes.
A redesigned ecosystem leveraging informatics is essential for routine behavioral medicine in oncology.